Clinical Trial: To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) Treatment

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Phase 4 Study of Azitromicin in the Treatment of PID

Brief Summary:

Objective: To compare two oral treatments: Ofloxacin + Metronidazole, and Azitromycin +Metronidazole in outpatients with Pelvic Inflammatory Disease.

Materials and Methods: Two hundred patients divided to two groups( A , B). Group A (treated by Ofloxacin 400 mg. + Metronidazole 500mg) and Group B (a single dose of oral Azitromicine 1gr + Metronidazole 500mg) for 10 days, were compared in terms of side effects and efficacy


Detailed Summary: Two hundred patients divided to two groups( A , B). Group A (treated by Ofloxacin 400 mg. + Metronidazole 500mg) and Group B (a single dose of oral Azitromicine 1gr + Metronidazole 500mg) for 10 days, were compared in terms of side effects and efficacy
Sponsor: Guilan University of Medical Sciences

Current Primary Outcome: to compare two oral antibiotic protocols in terms of side effects and efficacy. [ Time Frame: Jan 2010- Aug 2010 ]

side effects- and efficacy


Original Primary Outcome: Same as current

Current Secondary Outcome: single oral dose of Azitromicine could be the drug of choice in the outpatient treatment of Pelvic Inflammatory Disease [ Time Frame: Jan 2010- Aug 2010 ]

compliance and cost


Original Secondary Outcome: Same as current

Information By: Guilan University of Medical Sciences

Dates:
Date Received: November 15, 2010
Date Started: January 2010
Date Completion:
Last Updated: November 15, 2010
Last Verified: October 2010